ConductScience.org, home

Paper429321

Inactivation of rat renal phosphate-dependent glutaminase with 6-diazo-5-oxo-L-norleucine. Evidence for interaction at the glutamine binding site.

Shapiro RA and 2 others. J Biol Chem, 1979. Cited by 61 papers, by iCite.

Cite this record

ConductScience Library. Inactivation of rat renal phosphate-dependent glutaminase with 6-diazo-5-oxo-L-norleucine. Evidence for interaction at the glutamine binding site. Papers, record 429321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/429321

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inactivation of rat renal phosphate-dependent glutaminase with 6-diazo-5-oxo-L-norleucine. Evidence for interaction at the glutamine binding site.
PubMed
Journal
J Biol Chem
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
61
iCite
Relative citation ratio, by iCite
1.23
iCite
Revised in PubMed
2021-02-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shapiro RAR A
2Clark VMV M
3Curthoys NPN P

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Azo CompoundsMajor topic
DiazooxonorleucineMajor topic
GlutaminaseMajor topic
KidneyMajor topic
PhosphatesMajor topic
Animals
Binding Sites
Glutamine
Kinetics
Protein Binding
Rats

Source PubMed

Download CSV of topics

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.

PMIDTitleJournalYearIn PapersSource
39339370Discovery and Optimization of Ergosterol Peroxide Derivatives as Novel Glutaminase 1 Inhibitors for the Treatment of Triple-Negative Breast Cancer.Molecules2024https://conductscience.org/library/papers/39339370PubMed
36782138Identification of four metabolic subtypes and key prognostic markers in lung adenocarcinoma based on glycolytic and glutaminolytic pathways.BMC Cancer2023https://conductscience.org/library/papers/36782138PubMed
36655131Synthesis of Novel Kidney-Type Glutaminase Allosteric Inhibitors Targeting the Critical Lys-320 Residue.ACS Med Chem Lett2023https://conductscience.org/library/papers/36655131PubMed
34977582Biodegradable self-assembly micelles significantly enhanced the solubility, biological stability and in vivo antitumor efficacy of Hexylselen.RSC Chem Biol2021https://conductscience.org/library/papers/34977582PubMed
34678554Modulating glutamine metabolism to control viral immuno-inflammatory lesions.Cell Immunol2021https://conductscience.org/library/papers/34678554PubMed
33777357An efficient synthetic route to l-γ-methyleneglutamine and its amide derivatives, and their selective anticancer activity.RSC Adv2021https://conductscience.org/library/papers/33777357PubMed
33335484From Glucose to Lactate and Transiting Intermediates Through Mitochondria, Bypassing Pyruvate Kinase: Considerations for Cells Exhibiting Dimeric PKM2 or Otherwise Inhibited Kinase Activity.Front Physiol2020https://conductscience.org/library/papers/33335484PubMed
33322239The Molecular 'Myc-anisms' Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics.Int J Mol Sci2020https://conductscience.org/library/papers/33322239PubMed
32219214Kidney-Type Glutaminase Inhibitor Hexylselen Selectively Kills Cancer Cells via a Three-Pronged Mechanism.ACS Pharmacol Transl Sci2019https://conductscience.org/library/papers/32219214PubMed
32211323Metabolic Plasticity in Chemotherapy Resistance.Front Oncol2020https://conductscience.org/library/papers/32211323PubMed
32163417Glutamine supports the protection of tissue cells against the damage caused by cholesterol-dependent cytolysins from pathogenic bacteria.PLoS One2020https://conductscience.org/library/papers/32163417PubMed
31055988The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.Expert Opin Ther Targets2019https://conductscience.org/library/papers/31055988PubMed
30198844Glutathione de novo synthesis but not recycling process coordinates with glutamine catabolism to control redox homeostasis and directs murine T cell differentiation.Elife2018https://conductscience.org/library/papers/30198844PubMed
29969024Recent Progress in the Discovery of Allosteric Inhibitors of Kidney-Type Glutaminase.J Med Chem2019https://conductscience.org/library/papers/29969024PubMed
29888760Evaluating the Analgesic Effect of the GLS Inhibitor 6-Diazo-5-Oxo-L-Norleucine in Vivo.Pharm Pharmacol Int J2016https://conductscience.org/library/papers/29888760PubMed
29788892Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer.Curr Top Med Chem2018https://conductscience.org/library/papers/29788892PubMed
29750203Evaluating the Toxicity of the Analgesic Glutaminase Inhibitor 6-Diazo-5-Oxo-L-Norleucine in vitro and on Rat Dermal Skin Fibroblasts.MOJ Toxicol2015https://conductscience.org/library/papers/29750203PubMed
28950000Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.PLoS One2017https://conductscience.org/library/papers/28950000PubMed
28115589Targeting Metabolism as a Novel Therapeutic Approach to Autoimmunity, Inflammation, and Transplantation.J Immunol2017https://conductscience.org/library/papers/28115589PubMed
26640142Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax.Oncogene2016https://conductscience.org/library/papers/26640142PubMed

See all 38 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/429321

GET https://conductscience.org/api/papers/v1/429321/cited_by?page=2